Monopar Therapeutics Inc. (NASDAQ: MNPR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MONOPAR THERAPEUTICS INC.

Monopar Therapeutics Inc. (NASDAQ: MNPR)
Listen to this Section


$59.42
-0.1900 ( -0.32% ) 190.6K

Clinical Trial Pipeline Stages


Drug Name Stage
MNPR-101-ZrDetailsCancer Phase 1
MNPR-101-RITDetailsCancer Phase 1
MNPR-101-LuDetailsCancer Phase 1a
MNPR-101-ZrDetailsCancer, Solid tumor/s Phase 1

Market Data


Open $59.42
Previous Close $59.61
Volume 190.6K
Market Cap $405.70M
Day Range $59.48 - $64.26
52 Week Range $29.18 - $105.00
Shares Outstanding 6.70M
Change % -0.32%
Net Change ▼ -0.1900
Insider Ownership -0.14%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2019
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -388,247.00

Date Type Amount Purchased Purchaser
2024-10-30 Buy 1550.00 Radhakrishnan Karthik
2024-07-03 Sale -125000.00 Radhakrishnan Karthik
2024-07-02 Sale -8952.00 Cittadine Andrew
2024-07-02 Sale -24476.00 Robinson Chandler
2024-07-02 Sale -9957.00 Tsuchimoto Kim R
2024-06-21 Buy 12000.00 Cittadine Andrew
2024-06-17 Buy 12000.00 Cittadine Andrew
2024-06-05 Buy 12000.00 Cittadine Andrew
2024-05-31 Buy 12000.00 Cittadine Andrew
2024-05-30 Sale -84000.00 Robinson Chandler

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Aug 12, 2025
10-q Quarterly Reports 59 Aug 12, 2025
4 Insider transactions 1 Jul 16, 2025
4 Insider transactions 1 Jul 16, 2025
4 Insider transactions 1 Jul 16, 2025
4 Insider transactions 1 Jul 02, 2025
4 Insider transactions 1 Jul 02, 2025
8-k 8K-related 13 Jun 23, 2025

Latest News


× Before browsing our site, please accept our cookies policy